Apogee Therapeutics, Inc. (APGE)

SEC filing

Apogee Therapeutics, Inc.

APGE · CIK 1974640

4 · Nov 7, 2025 · Dambkowski Carl sold 10.79K shares at $55.07/share ($593.9K); exercised options for 8,060 shares

Dambkowski Carl sold 10.79K shares at $55.07/share ($593.9K); exercised options for 8,060 shares

OWNERSHIP DOCUMENT

xslF345X05/tm2530515-1_4seq1.xmlSEC.gov

Graphics and non-inline formats (not embedded below).